CEACAM1 Loss Links Inflammation to Insulin Resistance in Obesity and Non-Alcoholic Steatohepatitis (NASH)

Seminars in Immunopathology- Germany

doi 10.1007/s00281-013-0407-3

Full Text

Abstract

Available in

Date

November 21, 2013

Authors

Sonia M. Najjar

Lucia Russo

Publisher

Springer Science and Business Media LLC

Related search

CCN1 Promotes Hepatic Steatosis and Inflammation in Non-Alcoholic Steatohepatitis

Scientific Reports

Multidisciplinary

2020

English

Sorafenib Prevents Liver Fibrosis in a Non-Alcoholic Steatohepatitis (NASH) Rodent Model

Brazilian Journal of Medical and Biological Research

English

The Roles of Epigenetic Regulators and Inflammasome in Hepatocellular Carcinoma Tumorigenesis in Patients With Alcoholic Steatohepatitis (ASH) vs Non-Alcoholic Steatohepatitis (NASH)

Clinical Oncology and Research

2019

English

Hepatic Ceramide May Mediate Brain Insulin Resistance and Neurodegeneration in Type 2 Diabetes and Non-Alcoholic Steatohepatitis

Journal of Alzheimer's Disease

English

Multiple Hits, Including Oxidative Stress, as Pathogenesis and Treatment Target in Non-Alcoholic Steatohepatitis (NASH)

International Journal of Molecular Sciences

Organic Chemistry

Molecular Biology

Theoretical Chemistry

Inorganic Chemistry

Computer Science Applications

English

The Roles of Gap Junctional Intercellular Communication in Non-Alcoholic Steatohepatitis (NASH) and Liver Fibrosis

Proceedings for Annual Meeting of The Japanese Pharmacological Society

2020

English

732 Gender Differences in Hepatic Gene Expression of Patients With Non-Alcoholic Steatohepatitis (NASH)

English

Apoptosis and Cytokines in Non-Alcoholic Steatohepatitis

Clinics in Liver Disease

Hepatology

2009

English

Burden of Illness and Economic Model for Patients With Non-Alcoholic Steatohepatitis (NASH) in the United States

English

Amanote Research

CEACAM1 Loss Links Inflammation to Insulin Resistance in Obesity and Non-Alcoholic Steatohepatitis (NASH)

Seminars in Immunopathology- Germany

Full Text

Abstract

Categories

Date

Authors

Publisher

Related search

CCN1 Promotes Hepatic Steatosis and Inflammation in Non-Alcoholic Steatohepatitis

Sorafenib Prevents Liver Fibrosis in a Non-Alcoholic Steatohepatitis (NASH) Rodent Model

The Roles of Epigenetic Regulators and Inflammasome in Hepatocellular Carcinoma Tumorigenesis in Patients With Alcoholic Steatohepatitis (ASH) vs Non-Alcoholic Steatohepatitis (NASH)

Hepatic Ceramide May Mediate Brain Insulin Resistance and Neurodegeneration in Type 2 Diabetes and Non-Alcoholic Steatohepatitis

Multiple Hits, Including Oxidative Stress, as Pathogenesis and Treatment Target in Non-Alcoholic Steatohepatitis (NASH)

The Roles of Gap Junctional Intercellular Communication in Non-Alcoholic Steatohepatitis (NASH) and Liver Fibrosis

732 Gender Differences in Hepatic Gene Expression of Patients With Non-Alcoholic Steatohepatitis (NASH)

Apoptosis and Cytokines in Non-Alcoholic Steatohepatitis

Burden of Illness and Economic Model for Patients With Non-Alcoholic Steatohepatitis (NASH) in the United States